Top

Published in:

Open Access 01-12-2016 | Letter to the Editor

Phenylketonuria screening in the Republic of Macedonia

Authors: Mirjana Kocova, Violeta Anastasovska

Published in: Orphanet Journal of Rare Diseases | Issue 1/2016

Abstract

Phenylketonuria is an autosomal recessive inborn error of metabolism which can be prevented by early and continuous treatment. Therefore newborn screening for phenylketonuria has been introduced in many countries. We present here the results of the selective newborn screening for inborn errors of metabolism, including PKU, performed by tandem mass spectrometry which has been introduced in Macedonia since 2011.

Penrose LS. Phenylketonuria–a problem in eugenics. Lancet. 1946;1(6409):949–53.CrossRefPubMed

National Academy of Sciences. Genetic screening: programs, principles and research. Washington, D.C: National Research Council; 1975.

Hardelid P, Cortina-Borja M, Munro A, Jones H, Cleary M, Champion MP, Foo Y, Scriver CR, Dezateux C. The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England. Ann Hum Genet. 2008;72:65–71.PubMed

Zerjav Tansek M, Groselj U, Angelkova N, Anton D, Baric I, Djordjevic M, Grimci L, Ivanova M, Kadam A, Kotori V, Maksic H, Marginean O, Margineanu O, Miljanovic O, Moldovanu F, Muresan M, Nanu M, Samardzic M, Sarnavka V, Savov A, Stojiljkovic M, Suzic B, Tincheva R, Tahirovic H, Toromanovic A, Usurelu N, Battelino T. Phenylketonuria screening and management in southeastern Europe—survey results from 11 countries. Orphanet J Rare Dis. 2015;10:68–74.CrossRefPubMedPubMedCentral

State Statistical Office, Republic of Macedonia. Gross domestic product 2001–2014. Available at www.stat.gov.mk. Accessed 20 Oct 2015.

Kocova M, Anastasovska V. Phenylketonuria screening in the Republic of Macedonia. Orphanet J Rare Dis. 2015. in press.

Groselj U, Zerjav Tansek M, Battelino T. Fifty years of phenylketonuria newborn screening—A great success for many, but what about the rest? Mol Genet Metab. 2014;113:11–3.CrossRef

Sladkevicius E, Pollitt RJ, Mgadmi A, Guest JF. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya. Appl Health Econ Health Policy. 2010;8:407–20.CrossRefPubMed

Hagedorn TS, van Berkel P, Hammerschmidt G, Lhotáková M, Saludes RP. Requirements for a minimum standard of care for phenylketonuria: the patients’ perspective. Orphanet J Rare Dis. 2013;8:191.CrossRefPubMedPubMedCentral

Title: Phenylketonuria screening in the Republic of Macedonia
Authors: Mirjana Kocova
Violeta Anastasovska
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2016
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-016-0483-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Phenylketonuria screening in the Republic of Macedonia

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial

Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study

JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas

Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis

Novel homozygous RARS2 mutation in two siblings without pontocerebellar hypoplasia – further expansion of the phenotypic spectrum